medigraphic.com
SPANISH

Biotecnología Aplicada

ISSN 1027-2852 (Electronic)
ISSN 0864-4551 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 1

<< Back Next >>

Biotecnol Apl 2012; 29 (1)

In vitro activity of Surfactant Protein A against Leishmania amazonensis

Lugones Y, Blanco O, Faure R, Monzote L
Full text How to cite this article

Language: English
References: 23
Page: 35-37
PDF size: 138.14 Kb.


Key words:

Leishmania amazonensis, pulmonary surfactant, antimicrobial, SP-A.

ABSTRACT

Surfactant protein A (SP-A) is a hydrophilic pulmonary protein belonging to the collectin family, involved in lung homeostasis, the regulation of host defenses and inflammation. The present study addresses the activity of SP-A against promastigotes and amastigotes of Leishmania amazonensis and its cytotoxicity for host cells. SP-A exhibited similar activity against both parasite forms, with an IC50 of 34.0 ± 3.1 and 33.6 ± 1.1 µg/mL against promastigotes and amastigotes, respectively. It was moderately cytotoxic to peritoneal macrophages from BALB/c mice, exhibiting an IC50 value of 172.0 ± 6.1 µg/mL. This is the first report on the anti-leishmanial activity of SP-A.


REFERENCES

  1. Wright JR. Pulmonary surfactant: a front line of lung host defense. J Clin Invest. 2003;111(10):1453-5.

  2. Creuwels LA, van Golde LM, Haagsman HP. The pulmonary surfactant system: biochemical and clinical aspects. Lung. 1997;175(1):1-39.

  3. Possmayer F. A proposed nomenclature for pulmonary surfactant-associated proteins. Am Rev Respir Dis. 1988;138(4):990-8.

  4. Manzanares DA, Díaz E, Alfonso WC, Escobar AC, Colomé H, Muñoz MC, et al., inventors; Centro Nacional de Sanidad Agropecuaria, assignee. Surfactante Pulmonar Natural Porcino. Cuban Patent; CU 22479 A1. 1994 Dec 29.

  5. Awasthi S. Surfactant protein (SP)-A and SP-D as antimicrobial and immunotherapeutic agents. Recent Pat Antiinfect Drug Discov. 2010;5(2):115-23.

  6. Blanco O, Catala A. Surfactant protein A inhibits the non-enzymatic lipid peroxidation of porcine lung surfactant. Prostaglandins Leukot Essent Fatty Acids. 2001;65(4):185-90.

  7. Sanchez J, Blanco O, Martínez G, De Armas E, Fernández O, Faure R. La proteína A del surfactante porcino (SP-A) exhibe propiedades antioxidantes en el sistema Fenton. Rev Mex Cienc Farm. 2003;34(3):19-23.

  8. Sano H, Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol Immunol. 2005;42(3):279-87.

  9. McCormack FX. New concepts in collectin-mediated host defense at the air-liquid interface of the lung. Respirology. 2006;11 Suppl 1:S7-10.

  10. Blanco O, Sanchez Y, Manzanares D, Fernández O. Isolation of surfactant protein A, SP-A, from bronchoalveolar porcine lavage. Rev Salud Animal. 2000;22(3):180-2.

  11. Bodley AL, McGarry MW, Shapiro TA. Drug cytotoxicity assay for African trypanosomes and Leishmania species. J Infect Dis. 1995;172(4):1157-9.

  12. Torres-Santos EC, Moreira DL, Kaplan MA, Meirelles MN, Rossi-Bergmann B. Selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrob Agents Chemother. 1999;43(5):1234-41.

  13. Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, da Cunha Pinto A, et al. Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrob Agents Chemother. 2001;45(5):1349-54.

  14. Sladowski D, Steer SJ, Clothier RH, Balls M. An improved MTT assay. J Immunol Methods. 1993;157(1-2):203-7.

  15. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95(3):239-43.

  16. Herwaldt BL. Leishmaniasis. Lancet. 1999;354(9185):1191-9.

  17. Croft SL, Yardley V. Chemotherapy of leishmaniasis. Curr Pharm Des. 2002;8(4):319-42.

  18. Blanco O, Lugones Y, Diaz E, Monzote L. In vitro activity of the clinical pulmonary surfactant Surfacen(R) against Leishmania amazonensis. Rev Inst Med Trop Sao Paulo. 2011;53(4):235-8.

  19. Chan-Bacab MJ, Pena-Rodriguez LM. Plant natural products with leishmanicidal activity. Nat Prod Rep. 2001;18(6):674-88.

  20. Callahan HL, Portal AC, Devereaux R, Grogl M. An axenic amastigote system for drug screening. Antimicrob Agents Chemother. 1997;41(4):818-22.

  21. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest. 2003;111(10):1589-602.

  22. Ledford JG, Goto H, Potts EN, Degan S, Chu HW, Voelker DR, et al. SP-A preserves airway homeostasis during Mycoplasma pneumoniae infection in mice. J Immunol. 2009;182(12):7818-27.

  23. McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GS, Jr. Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem. 2003;278(38):36250-6.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Biotecnol Apl. 2012;29